Vitaxin

http://dbpedia.org/resource/Vitaxin an entity of type: Thing

Vitaxin (MEDI-523) is a humanized monoclonal antibody against the vascular integrin alpha-v beta-3. It is shown to be a promising angiogenesis inhibitor used in the treatment of some forms of cancer. Vitaxin was in 2002 being studied for rheumatoid arthritis. It is the developmental precursor of Etaracizumab (MEDI-522). Both are derived from the mouse antibody LM609. Vitaxin is safe for humans. It has little effect on advanced cancer. 4. == References == rdf:langString

rdfs:label

rdf:langString Vitaxin

dbpedia-owl:wikiPageID

xsd:integer 19359506

dbpedia-owl:wikiPageRevisionID

xsd:integer 1123985830

dbpprop:atcPrefix

rdf:langString none

dbpprop:chemspiderid

rdf:langString none

dbpprop:source

rdf:langString zu/o

dbpprop:target

rdf:langString alpha-v beta-3 integrin

dbpprop:tradename

rdf:langString Vitaxin

dbpprop:type

rdf:langString mab

dbpprop:verifiedfields

rdf:langString changed

dbpprop:watchedfields

rdf:langString changed

dbpedia-owl:abstract

rdf:langString Vitaxin (MEDI-523) is a humanized monoclonal antibody against the vascular integrin alpha-v beta-3. It is shown to be a promising angiogenesis inhibitor used in the treatment of some forms of cancer. Vitaxin was in 2002 being studied for rheumatoid arthritis. It is the developmental precursor of Etaracizumab (MEDI-522). Both are derived from the mouse antibody LM609. Vitaxin is safe for humans. It has little effect on advanced cancer. 4. == References ==

dbpprop:mabType

rdf:langString mab

dbpedia-owl:wikiPageLength

xsd:nonNegativeInteger 3426

dbpedia-owl:alternativeName

rdf:langString Vitaxin

rdf:type

owl:Thing

<http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject>

dbpedia-owl:ChemicalSubstance

<http://www.wikidata.org/entity/Q8386>

yago:WikicatAngiogenesisInhibitors